Abrysvo act-o-vials
Ended Awarded
- Contract number
- SPE2DR26FHZ5X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,602
Award facts
- Contract value 100% obligated
- $21,601.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,601.92 to AmerisourceBergen Drug Corp for Act-O-Vials on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement needs through its extensive portfolio of delivery orders with the DLA Medical Supply Chain. The company's federal contracts demonstrate capability across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for Act-O-Vials supports the DLA's broader mission to provide critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract reflects AmerisourceBergen's position as a key vendor within the federal pharmaceutical supply chain, selected through open competition to meet specific medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FHZ5X?
SPE2DR26FHZ5X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FHZ5X worth?
The government has obligated $21,602 on SPE2DR26FHZ5X.
Is contract SPE2DR26FHZ5X an order under another contract?
Yes. SPE2DR26FHZ5X is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHZ5X competed?
The extent of competition for SPE2DR26FHZ5X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award